Serum IGF-1 and IGF-2 as biomarkers in idiopathic Parkinson's disease: Correlation with disease stages

dc.contributor.authorCakir, E.
dc.contributor.authorOzyilmaz, A.
dc.contributor.authorAlpay, M.
dc.contributor.authorUyurca, S.
dc.date.accessioned2026-07-01T11:40:17Z
dc.date.available2026-07-01T11:40:17Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description11th Congress of the European-Academy-of-Neurology (EAN) -- JUN 21-24, 2025 -- Helsinki, FINLAND
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Acad Neurol
dc.identifier.issn1351-5101
dc.identifier.issn1468-1331
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23742
dc.identifier.volume32
dc.identifier.wosWOS:001628319700128
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Neurology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20260623
dc.subject[Keyword Not Available]
dc.titleSerum IGF-1 and IGF-2 as biomarkers in idiopathic Parkinson's disease: Correlation with disease stages
dc.typeConference Object

Dosyalar